In this article, we will list the 5 Hidden Penny Stocks to Invest In. Please visit 7 Hidden Penny Stocks to Invest In if you would like to see the extended list and the methodology behind it.

5. UWM Holdings Corporation (NYSE:UWMC)

Upside Potential as of June 10, 2026: 105.76%

Number of Hedge Fund Holders: 40

According to a June 5 report by TheFly, Keefe Bruyette said UWM Holdings Corporation (NYSE:UWMC) shares reached an all-time low the day before, significantly underperforming its mortgage banking competitors over the past month. The analyst attributed this to worries around the company’s leverage in a “higher-for-longer” mortgage rate landscape.

While maintaining its Market Perform rating and a price target of $4.50, Keefe noted that a major driver of UWM’s weaker leverage is its dividend. Additionally, the firm asserted that the Two Harbors acquisition “no longer appears compelling if it’s largely for cash,” and once this is resolved, a dividend cut is likely. As stated by the firm,

“Despite potential initial share weakness on a dividend cut, we think it is likely to be a meaningful, longer-term positive for capital and valuation.”

Back on May 15, Keefe, Bruyette & Woods reaffirmed its stance on UWM Holdings Corporation (NYSE:UWMC) with a Market Perform rating and a $4.50 price target. This comes after the company’s investor day, in which management indicated that the broker channel’s share could grow from the current 28% to more than 50%. The growth opportunity arising from this, in addition to other tailwinds, makes UWMC one of the hidden penny stocks to invest in.

UWM Holdings Corporation (NYSE:UWMC) is a Michigan-based company specializing in origination, sale, and servicing residential mortgage lending. Founded in 1986, the company originates primarily from conforming and government loans.

4. Americas Gold and Silver Corporation (NYSEAMERICAN:USAS)

Upside Potential as of June 10, 2026: 130.75%

Number of Hedge Fund Holders: 18

On May 19, BMO Capital lifted the price target on Americas Gold and Silver Corporation (NYSEAMERICAN:USAS) from C$10 to C$12 and reiterated an Outperform rating. While highlighting that Galena Complex production is on track, the firm remained optimistic about the company’s strong execution of its operational optimization plan.

Even during its Q1 FY2026 earnings call on May 15, Americas Gold and Silver Corporation (NYSEAMERICAN:USAS) outlined sustained momentum across the Americas, thanks to production growth and strong cost performance. What’s even more interesting is the company’s increased strategic focus on antimony, as Galena remains well-positioned as one of the few active domestic sources of antimony production in the United States.

If we consider the company’s 3-year return, Americas Gold and Silver Corporation (NYSEAMERICAN:USAS) has outperformed the market by an impressive 285%. Additionally, the company has a solid quarterly revenue growth (yoy) of 187.90%. No wonder Americas Gold and Silver Corporation (NYSEAMERICAN:USAS) is among the hidden penny stocks to invest in.

Americas Gold and Silver Corporation (NYSEAMERICAN:USAS) is a Canadian company specializing in mineral properties. Founded in 1998, the company develops gold, silver, zinc, lead, and other by-products.

3. i-80 Gold Corp. (NYSEAMERICAN:IAUX)

Upside Potential as of June 10, 2026: 139.19%

Number of Hedge Fund Holders: 32

On June 2, Freedom Broker elevated the price target on i-80 Gold Corp. (NYSEAMERICAN:IAUX) to $2.60 from $2 and reiterated a Buy rating. The firm highlighted the company’s stronger operational Q1, driven by enhanced gold sales volumes, higher realized gold prices, and the successful execution of its recapitalization plan, bringing in approximately $787.5 million in funding.

The firm believes that the investors will focus on minimizing financing risks instead of current financial results. What’s even more interesting is that the funding for the first and second stages of the Nevada development strategy is already fully secured. These developments make i-80 Gold Corp. (NYSEAMERICAN:IAUX) one of the hidden penny stocks to invest in now.

The core initiatives of i-80 Gold Corp. (NYSEAMERICAN:IAUX) include Granite Creek and Cove projects, first gold production at Upper Archimedes by the year-end, and Lone Tree complex reconstruction, the firm noted, adding that the successful implementation of these will solidify the company’s position among precious metals producers in Nevada. This is reinforced by the company’s one-year return of 120.97%, significantly higher than the market’s 29.23% return.

i-80 Gold Corp. (NYSEAMERICAN:IAUX) is a Nevada-based mining company exploring and developing gold and silver mineral deposits. Incorporated in 2020, the company also explores for polymetallic deposits.

2. Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

Upside Potential as of June 10, 2026: 151.32%

Number of Hedge Fund Holders: 33

As of June 10, Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) was trading near the low levels reported on June 3, before the stock appreciated following the Australian approval of Amtagvi. The stock has returned to its pre-approval levels.

On June 4, TheFly reported that Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) has received conditional approval of Amtagvi from the Therapeutic Goods Administration of Australia. This marks the third marketing authorization for Amtagvi, underscoring a huge step forward in a market with the highest rate of melanoma globally.

Overall, 80% of the analysts are bullish on Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), with the remaining 20% neutral. On May 8, Chardan trimmed the price target on the company from $16 to $14 and reiterated a Buy rating. In a research note, the analyst attributed this model readjustment to the revised Amtagvi launch guidance. Management now forecasts Q2 Amtagvi revenue to be between $79 million and $81 million. With this potential, the company has secured a spot among the hidden penny stocks to invest in.

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), incorporated in 2007, is a California-based commercial-stage biopharmaceutical company specializing in cell therapies for metastatic melanoma and other solid tumor cancers.

1. AtaiBeckley Inc. (NASDAQ:ATAI)

Upside Potential as of June 10, 2026: 283.60%

Number of Hedge Fund Holders: 35

On June 8, H.C. Wainwright maintained a Buy rating on AtaiBeckley Inc. (NASDAQ:ATAI) with a price target of $25. With the highest 1-year price target among analysts, the firm’s estimate implies 561.38% upside potential.

This comes after H.C. Wainwright hosted the company’s management on June 2, featuring the CEO, CFO, and VP Investor Relations. The discussion revolved around BPL-003, which remains the key value driver as the company advances the Phase 3 program (ReConnection) in treatment-resistant depression, the firm noted. That said, the firm continues to view BPL-003 among the most differentiated short-duration psychedelic assets in development. Indeed, AtaiBeckley Inc. (NASDAQ:ATAI) is among the hidden penny stocks to buy.

Back on May 28, AtaiBeckley Inc. (NASDAQ:ATAI) announced the launch of its Patient Impact Grant Program. Dedicated to improving mental health outcomes, the initiative will provide three $20,000 grants to NGOs. This is in addition to the company’s drug development activities. As said by CMO Kevin Craig,

“Real progress in mental health doesn’t happen in isolation – it happens when we innovate responsibly, listen to patients, and invest in the people driving change on the ground.”

AtaiBeckley Inc. (NASDAQ:ATAI), founded in 2018, is a New York-based clinical-stage biopharmaceutical company providing mental health treatments in the United States, Germany, and Canada.

READ NEXT: Starter Stock Portfolio: 14 Safe Stocks to Buy Now and 40 Most Popular Stocks Among Hedge Funds Heading Into 2026.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.